SEC Form 4 · accession 0001209191-15-056543
Lantheus Holdings, Inc. · LNTH
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Cesare Orlandi
Officer — Chief Medical Officer
Period of report
Jun 25, 2015
Accepted (ET)
Jun 25, 2015 · 7:33 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001521036
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $21.10 | Jun 25, 2015 | D | 6,673 | D | — | Mar 4, 2023 | Common Stock | 6,673 | 0 | D |
| Stock Option (right to buy)F1 | $21.10 | Jun 25, 2015 | A | 6,673 | A | — | Mar 4, 2023 | Common Stock | 6,673 | 6,673 | D |
Explanation of responses
- F1The reported transactions involve an amendment applicable to outstanding unvested options, resulting in the deemed cancellation of the "old" options and the grant of replacement options. The options were originally granted on March 4, 2013 and provide for vesting in up to four equal annual installments, based on the level of LNTH's satisfaction of certain performance criteria for each of fiscal years 2013, 2014, 2015 and 2016. The amendment provides for additional vesting on the third anniversary of the amendment date (or the day before any earlier expiration) of any options that remain unvested at that time.